When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DCPH - Deciphera's rebastinib shows encouraging efficacy in ovarian cancer
Deciphera Pharmaceuticals Inc.
Deciphera Pharmaceuticals (NASDAQ:DCPH)announces data from the ovarian cancer cohort in Part 2 of the ongoing Phase 1b/2 study of rebastinib, the selective TIE2 inhibitor, in combination with paclitaxel and from Part 1 of the Phase 1b/2 study of rebastinib in combination with carboplatin.
More news on: Deciphera Pharmaceuticals, Inc., Healthcare stocks news,